Adipotide (TP01/FTPP) is an experimental peptidomimetic agent designed to treat obesity by selectively inducing apoptosis (programmed cell death) in the blood vessels of white adipose tissue. Studies in monkeys showed rapid weight loss (over 11% in 28 days) and improved insulin resistance. It is currently an investigational compound not approved